Studying of Natural Constituents' Treatment of Plantar Warts

Early Phase 1

Completed

• Conditions: Plantar Wart
• Interventions: Drug: Banaba Leaf Extract

• Registration Number: NCT05592041
• Lead Sponsor: Deraya University

Brief Summary

Moringa banana nigella and Banna coat extract were prepared and formulated in the form of bi gel for transdermal delivery of these plant extracts. The formulation was prepared and charterized for organoleptic charters, morphology, and penetration efficacy. The optimised formulation was assessed clinically on patients suffering from plantar warts. The clinical study was phase 1 and interventional randomised allocation.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2022-10-17
• Study Start: 2022-10-20
• Study First Submitted QC: 2022-10-21
• Study First Posted: 2022-10-24
• Primary Completion: 2022-12-18
• Study Completion: 2023-01-10
• Status Verified: 2024-05
• Last Update Submitted: 2024-05-15
• Last Update Posted: 2024-05-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• Male or female patient aged 18 years or more.
• Clinical evaluation
• Number of warts lower than 10 on the 2 feet and total diameter of warts lower than 10 cm

Exclusion Criteria

• Patient suspected to be immunocompromised
• Patient aged under 18 years
• Patient refusing to sign the consent
• Pregnant or lactating women

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Treatment group (Group I)	Banaba Leaf Extract	-

Primary Outcome Measures

Name	Time	Method
Clinical assessment of warts curement	30 days	Diameter of wart in cm
Complete clinical remission of the warts	30 days	Number of warts (counts)

Secondary Outcome Measures

Name	Time	Method
Pain asssesment	30 days	pain was assesed by VAS scoring (0) the least to (5) highest

Trial Locations

Locations (1)

Soad A. Mohamad; 🇪🇬 Minya, Egypt